Skip to Content
  • At Your Newsstand Today

    I’d like to recommend the latest issue of Science, which has a multi-part special section on drug discovery. (Problem is, that link will only work if you… Read More
  • And It Goes Like This

    It’s no wonder that there’s still so much argument over autism and vaccines. Paranoia is an endlessly renewable resource – big glowing hunks o… Read More
  • A Day in the Life of Peter Rost

    I last wrote about Pfizer executive Peter Rost back in September, after he’d unburdened himself on the subject of Canadian drug reimportation. As readers… Read More
  • Biotech At Last, Eh?

    There’s a recent piece in Business Week Online that says nice things about the biotech and pharma industries, and I should be happy about that. But there… Read More
  • Preach It, Brother

    Saturday’s New York Times had an astonishingly sensible article about the drug reimportation issue. (You can go ahead and insert the phrase “. . .es… Read More
  • Angell’s Book

    Update: (Much) more on this topic here. Readers are already asking me if I’ve read Marcia Angell’s new book, “The Truth About the Drug Compani… Read More
  • Sic Transit Gloria Mundi

    So Entremed is finally giving up on its celebrated peptide drug candidates, angiostatin and endostatin. I’m sorry to see what the company, and its employe… Read More
  • Not Even Funny

    I’m late to this particular party – see Charles Murtaugh and Medpundit for the low-down on a particularly irritating LA Times column. (It requires r… Read More
Page 10 of 11« First...7891011